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WHAT THIS PAPER ADDS
 This study demonstrates that patients with uncomplicated varicose veins (VV) often have severe symptoms that adversely affect
their health-related quality of life (HRQL). These patients, who would often not be offered treatment for their varicose veins in
a publicly-funded health system, have a lot to gain from treatment. This is the ﬁrst study that demonstrates that HRQL is lower in
patients with symptomatic VV irrespective of the clinical severity of disease.a r t i c l e i n f o
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Objectives: To determine the relationship between lower limb symptoms and generic health-related
quality of life (HRQL) in patients with varicose veins (VV).
Methods: 284 patients on the waiting list for VV treatment completed the Short Form-12 (SF12) and
a questionnaire asking about the presence of lower limb symptoms commonly attributed to venous
disease (pain or ache, itching, tingling, cramp, restless legs, a feeling of swelling, and heaviness).
Results: Median age was 57 years (interquartile range 45e67); 100 (35%) were male, and 182 (64%) had
CEAP clinical grade 2 or 3 disease. JonckheereeTerpstra test for trend revealed that both physical
(P < .0005) and mental (P ¼ .001) HRQL worsened as the reported number of symptoms increased.
Patients reporting tingling (P ¼ .016, ManneWhitney U test), cramp (P ¼ .001), restless legs (P < .0005),
swelling (P < .0005), and heaviness (P < .0005) had a signiﬁcantly worse physical HRQL than those who
did not. Mental HRQL was also signiﬁcantly worse in patients with tingling (P ¼ .010), cramp (P ¼ .008),
restless legs (P ¼ .040), swelling (P ¼ .001), and heaviness (P ¼ .035).
These signiﬁcant relationships remained, and pain was also correlated with worse physical HRQL
(P ¼ .011), when linear regression was performed to control for CEAP clinical grade, age and sex.
Conclusions: Physical and mental HRQL is signiﬁcantly worse in VV patients with lower limb symptoms
irrespective of the clinical stage of disease. This observation conﬁrms that VV are not primarily
a cosmetic problem and that NHS rationing of treatment to those with CEAP C4-6 disease excludes many
patients who would beneﬁt from intervention in terms of HRQL. Generic HRQL instruments also allow
comparison with interventions for other chronic conditions.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Patient satisfaction including resolution of symptoms and
improvement in health-related quality of life (HRQL) are increas-
ingly recognised as important treatment outcome measures,University, Department of
Hospital, Lode Lane, Solihull,
86.
. Darvall).
ciety for Vascular Surgery. Publisheparticularly in chronic venous insufﬁciency (CVI) wheremortality is
low.1 Treatment for varicose veins (VV) has been shown to improve
HRQL and eradicate symptoms in a highly cost-effective manner.2,3
However, in the United Kingdom (UK) National Health Service
(NHS) for ﬁnancial reasons non-reimbursement for the treatment
of symptomatic, but as yet uncomplicated (CEAP C2-3), VV is
widespread.4,5
The presence of lower limb symptoms in the general population
has been previously shown to be inconsistently associated with
CEAP clinical grade, signs of CVI, and also the degree of superﬁciald by Elsevier Ltd. All rights reserved.
Table 1
Patient and disease characteristics.
Parameter
No. of patients 284
No. of legs 375
Age: median (interquartile range) in years 57 (45e67)
Sex
Male 100 (35.2)
Female 184 (64.8)
CEAP clinical grade
C2 228 (60.8)
C3 25 (6.7)
C4 84 (22.4)
C5 20 (5.3)
C6 18 (4.8)
A(E)tiology
Primary (Ep) 375 (100)
Secondary (Es) 0 (0)
Anatomical patterns of venous reﬂux
Superﬁcial and deep (Asd) 7 (1.9)
Superﬁcial only (As) 368 (98.1)
Primary GSV 251 (66.9)
Recurrent GSV 97 (25.9)
Primary SSV 54 (14.4)
Recurrent SSV 15 (4.0)
Pathophysiological classiﬁcation
Reﬂux (Pr) 344 (100)
Obstruction (Po) 0 (0)
Figure 1. The number of lower limb symptoms reported according to CEAP clinical
grade.
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patients with uncomplicated (CEAP C2 and C3) VV can have
signiﬁcant symptoms and consequent reduced HRQL that could be
improved by treatment.
The aim of this study is to determine the relationship between
lower limb symptoms and generic HRQL in patients with VV.
Methods
Patients and questionnaires
Local ethical committee approval and written informed consent
were obtained. During the study period the local Primary Care Trust
(PCT) funded treatment for all symptomatic VV, both complicated
(CEAP C4-6) and uncomplicated (CEAP C2 and C3).
Patients with symptomatic VV already booked for treatment
completed the Short Form-12 (SF12) and a questionnaire asking
about the presence of a number of lower limb symptoms that they
attributed to their CVI. The symptoms, taken from the Edinburgh
Vein Study (EVS), were pain or ache, itching, tingling, cramp,
restless legs, a feeling of swelling, and heaviness. Patients were
asked to bring the completed questionnaires with themwhen they
attended hospital for treatment.
Responses to the 12 questions of the SF12 were used to calculate
Physical Component Summary (PCS) and Mental Component
Summary (MCS) scores. These scores were normalised to UK pop-
ulation norms, where the mean PCS and MCS for the general
population is 50. A higher score indicates a better HRQL.
The presence of each symptom, attributed by the patient to their
CVD, was recorded as present or absent. If the venous disease was
bilateral the symptom was recorded as present if it was present in
either leg.
Baseline information was collected at the time of attendance for
treatment, and included age, gender, the presence of bilateral
disease, and the CEAP clinical grade of both legs (the worst was
used for analysis).9
Statistical analysis
Non-parametric methods within Statistical Package for the
Social Sciences (SPSS) version 17.0 (SPSS, Chicago, IL, USA) were
used. The JonckheereeTerpstra test (a non-parametric alternative
to analysis of variance) was used to assess trend in PCS and MCS
across groups; ManneWhitney U (MWU) test was used to examine
the difference in median PCS and MCS according to the presence or
absence of each lower limb symptom. Finally, linear regression was
performed to control for CEAP clinical grade, age and sex.
Results
Questionnaires were sent to 395 consecutive patients. Of these,
284 (72%) completed both questionnaires. Patient and disease
characteristics are shown in Table 1. There were no signiﬁcant
differences between the group of patients who completed the
questionnaires and the patients who did not in terms of age,
gender, CEAP clinical grade, bilateral disease and treated veins (GSV
or SSV) and recurrent disease.
Number of lower limb symptoms and HRQL
Patients were allocated according to how many symptoms they
had (out of a total of 7) into three groups: 1e2 symptoms (18%), 3e4
symptoms (35%), and 5e7 symptoms (47%). There was no signiﬁ-
cant relationship between the number of symptoms and CEAP
clinical grade (Fig. 1).The JonckheereeTerpstra test was used to assess trend in PCS
and MCS across the groups. Both median PCS (P < .0005) and MCS
(P ¼ .001) worsened as the number of symptoms increased (Fig. 2).
Speciﬁc lower limb symptoms and physical HRQL (PCS)
Patients reporting tingling (P ¼ .016, MWU), cramp (P ¼ .001),
restless legs (P < .0005), swelling (P < .0005), and heaviness
(P < .0005) had a signiﬁcantly worse physical HRQL (PCS) than
those who did not (Fig. 3).
Speciﬁc lower limb symptoms and mental HRQL (MCS)
Mental HRQL (MCS) was also signiﬁcantly worse in patients
with tingling (P ¼ .010), cramp (P ¼ .008), restless legs (P ¼ .040),
swelling (P ¼ .001), and heaviness (P ¼ .035), than those without
these symptoms (Fig. 4).
Further analysis
Increasing CEAP clinical grade and age were signiﬁcantly asso-
ciated with a worse HRQL on univariate analysis. When linear
Figure 2. Box and whisker plots of HRQL scores by the number of lower limb symptoms.
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signiﬁcant relationships between HRQL and individual symptoms
remained, and pain was also correlated with worse physical HRQL
(P ¼ .001).
Discussion
The main ﬁnding of the current study is that physical and
mental HRQL is signiﬁcantly worse in VV patients with lower limb
symptoms irrespective of the CEAP clinical grade of disease.
Traditionally, the presence of one or more lower limb symptoms
thought likely to be due to CVI, together with duplex, hand-held
Doppler or clinical evidence of saphenous reﬂux, has been
considered an indication for intervention.6 In 2000, the National
Institute for Health and Clinical Excellence (NICE) published guid-
ance for general practitioners on who should be referred for VV
treatment.10 They recommended referral for patients with either
signiﬁcant symptoms from their VV resulting in a reduction in their
HRQL, or those with complications of VV, namely ulceration,
bleeding, thrombophlebitis or extensive skin changes. It is clear
from questionnaire studies that some PCTs have taken this further
for local ﬁnancial reasons and only reimburse treatment for
“complicated” (CEAP C4-6) VV.5,11e13 The “excuse” for such
rationing may have been inconsistent relationships that had
previously been reported between lower limb symptoms and
severity of CVI, both clinical and on DUS; as well as the lack of good
evidence that treating such VV was cost-effective.6e8,14,15
Over the last decade it has become abundantly clear that
treatment of VV, whether by surgery or a newer minimally invasive
option, improves both symptoms and HRQL, and results in highFigure 3. The effect of speciﬁc lower limb symptoms on physical HRQL (PCS).levels of patient satisfaction.2,16e27 Results of a recent randomized
trial have also shown that surgery for uncomplicated VV gives
a signiﬁcant beneﬁt over conservative treatment in terms of HRQL,
health status and patient satisfaction at a relatively small cost to the
NHS.2,3 Despite this, rationing continues. We have also previously
found a much greater improvement in SF12-PCS in the 12 months
after ultrasound-guided foam sclerotherapy (UGFS) for VV, in the
patients with CEAP C2-3 disease compared with those with CEAP
C4-6 disease.25
Using a generic HRQL score allows health providers to compare
interventions for different conditions to enable appropriate allo-
cation of resources.27 The relative priority of VV treatment,
compared to other procedures, has not been well-deﬁned. For
example, our group has previously found that the improvement in
generic physical and mental HRQL (measured by SF12) in the 12
months after surgery, was the same between patients having
surgery for VV and those undergoing laparoscopic cholecystectomy
for biliary colic.28
PROMS (Patient Reported Outcome Measures) is a Department
of Health-led programme in the UK, requiring collection of HRQL
data before and after elective surgery for unilateral hip and knee
replacements, groin hernia and VV surgeries since April 2009.29
PROMS published their ﬁrst report in August 2011, which found
that generic HRQL improvement, measured by EQ-5D index and
EQ-VAS, was slightly better following VV surgery, compared with
groin hernia surgery.29 So, why should treatment for VV be
rationed, rather than elective groin hernia or gallbladder surgery?
In this study we only used a generic measure of HRQL, whereas
it is recommended that for a full assessment both generic and
disease-speciﬁc instruments should be used.1 The reason for this isFigure 4. The effect of speciﬁc lower limb symptoms on mental HRQL (MCS).
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Varicose Vein Symptom Severity Score (AVSS) and the presence of
symptoms would be obvious, expected and previously demon-
strated, however, it was a little surprising to see that the presence of
lower limb symptoms had such a marked effect on the physical and
mental health of patients. In addition, this study also conﬁrms that
the SF12, a very short and easy to complete questionnaire, is both
responsive and sensitive to change in the CVD population, obvi-
ating the need for more lengthy, complicated instruments. In our
experience, these two questionnaires (SF12 and AVSS) are easy to
administer in the clinical setting and could be used in combination
as a screening tool to aid selection of patients for treatment.
The response rate of 72% in this study is in line with other
questionnaire studies including VV patients.16,27,30 Questionnaires
were administered by post which probably reduced the response
rate, but prevented the social desirability bias associated with
interview. Also, patients were unlikely to inﬂate their symptoms
(“fake bad”) in this study as they were already attending for
treatment at the time of completing the questionnaires.
In conclusion, these observations conﬁrm that VV are not
primarily a cosmetic problem and that NHS rationing of treatment
to those with complicated VV excludes many patients with a lot to
gain.Conﬂict of Interest/Funding
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